NCT00959218: Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis |
|
|
| Completed | 3 | 240 | Europe | Dronabinol, (-)trans-delta9-tetrahydrocannabinol, Placebo | Bionorica Research GmbH | Central Neuropathic Pain in Multiple Sclerosis | 03/10 | 04/10 | | |
2006-004255-38: Multi-centre, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of the pain relieving effect of Dronabinol in patients with multiple sclerosis associated with central neuropathic pain |
|
|
| Completed | 3 | 240 | Europe | dronabinol, cnp-MS-0601, Oral solution | Bionorica research GmbH | Patients with multiple sclerosis associated with central neuropathic pain | | | | |
NCT01598896: Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia |
|
|
| Terminated | 2/3 | 12 | US | Dronabinol, Marinol, CSA Drug Code 7369, Schedule III, NDC 54868-3189-0, Clonidine, Catapres, NDC 16590-266-30, Placebo | Mclean Hospital, Brain & Behavior Research Foundation | Cannabis Dependence, Marijuana Dependence | 08/17 | 08/17 | | |
